Could a pill ease the crushing fatigue of long COVID?
NCT ID NCT06597396
Summary
This study is testing whether an oral medication called abrocitinib can help reduce severe fatigue in adults living with Long COVID. It will compare two different doses of the drug against a placebo pill over 12 weeks. The goal is to see if the treatment improves energy levels and overall health status for people struggling with this persistent symptom.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE SYMPTOM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.